tradingkey.logo

Catheter Precision Inc

VTAK
1.770USD
-0.040-2.21%
收盘 12/24, 13:00美东报价延迟15分钟
2.92M总市值
0.05市盈率 TTM

Catheter Precision Inc

1.770
-0.040-2.21%

关于 Catheter Precision Inc 公司

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc简介

公司代码VTAK
公司名称Catheter Precision Inc
上市日期Sep 27, 2018
CEOJenkins (David A)
员工数量22
证券类型Ordinary Share
年结日Sep 27
公司地址1670 Highway 160 West
城市FORT MILL
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编29708
电话19736912000
网址https://www.ramed.com/
公司代码VTAK
上市日期Sep 27, 2018
CEOJenkins (David A)

Catheter Precision Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+118.07%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+118.07%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
173.00K
81.60%
All other countries
39.00K
18.40%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月4日 周四
更新时间: 12月4日 周四
持股股东
股东类型
持股股东
持股股东
占比
Jenkins Family Charitable Institute
2.21%
Jenkins (David A)
1.34%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
Manulife Investment Management (North America) Limited
0.03%
其他
96.09%
持股股东
持股股东
占比
Jenkins Family Charitable Institute
2.21%
Jenkins (David A)
1.34%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
Manulife Investment Management (North America) Limited
0.03%
其他
96.09%
股东类型
持股股东
占比
Corporation
2.43%
Individual Investor
1.47%
Investment Advisor
0.03%
其他
96.07%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
23
24.65K
1.66%
-10.09K
2025Q2
30
1.62M
12.88%
+225.25K
2025Q1
34
1.39M
13.16%
+226.78K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Jenkins Family Charitable Institute
36.85K
2.48%
+10.53K
+39.98%
Jun 05, 2025
Jenkins (David A)
10.22K
0.69%
-2.00
-0.02%
Sep 10, 2025
FatBoy Capital LP
3.73K
0.25%
--
--
Jan 29, 2025
Caruso (James Joseph)
1.84K
0.12%
+10.00
+0.55%
Sep 10, 2025
Jenkins (Casey A)
310.00
0.02%
+16.00
+5.44%
Jun 05, 2025
Jenkins Linda A
12.00
0%
--
--
Jan 29, 2025
BofA Global Research (US)
6.00
0%
+2.00
+50.00%
Jun 30, 2025
Harbour Investments, Inc
8.00
0%
--
--
Jun 30, 2025
SBI Securities Co., Ltd.
58.00
0%
+58.00
--
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
公告日期
类型
比率
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Nov 16, 2020
Merger
25→1
查看更多

常见问题

Catheter Precision Inc的前五大股东是谁?

Catheter Precision Inc 的前五大股东如下:
Jenkins Family Charitable Institute持有股份:36.85K,占总股份比例:2.48%。
Jenkins (David A)持有股份:10.22K,占总股份比例:0.69%。
FatBoy Capital LP持有股份:3.73K,占总股份比例:0.25%。
Caruso (James Joseph)持有股份:1.84K,占总股份比例:0.12%。
Jenkins (Casey A)持有股份:310.00,占总股份比例:0.02%。

Catheter Precision Inc的前三大股东类型是什么?

Catheter Precision Inc 的前三大股东类型分别是:
Jenkins Family Charitable Institute
Jenkins (David A)
FatBoy Capital LP

有多少机构持有Catheter Precision Inc(VTAK)的股份?

截至2025Q3,共有23家机构持有Catheter Precision Inc的股份,合计持有的股份价值约为24.65K,占公司总股份的1.66%。与2025Q2相比,机构持股有所增加,增幅为-11.22%。

哪个业务部门对Catheter Precision Inc的收入贡献最大?

在FY2025Q2,--业务部门对Catheter Precision Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI